# Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft

> **NCT01305863** · NA · UNKNOWN · sponsor: **Tissue Genesis** · enrollment: 60 (estimated)

## Conditions studied

- Lower Limb Ischemia

## Interventions

- **DEVICE:** ASC coated ePTFE vascular graft
- **DEVICE:** Propaten graft

## Key facts

- **NCT ID:** NCT01305863
- **Lead sponsor:** Tissue Genesis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2022-04
- **Final completion:** 2022-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305863, "Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01305863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*